Jiangxi Synergy Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangxi Synergy Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Fujian Cosunter Pharmaceutical Co Ltd
sales of 414.86 million Chinese Renmimbi [US$60.92 million]
of which 100%
Wuhan Hvsen Biotechnology Co Ltd
(427.22 million Chinese Renmimbi [US$62.73 million]
of which 26%
was Acetylisovaleryltylosin Tartrate), and
Lansen Pharmaceutical Holdings Limited
(428.60 million Chinese Renmimbi [US$62.94 million]
of which 81%
was Specialty Pharmaceuticals).
During the year ended December of 2019, sales at
Jiangxi Synergy Pharmaceutical Co Ltd were 413.06 million Chinese Renmimbi (US$60.65 million).
increase of 54.6%
versus 2018, when the company's sales were 267.12 million Chinese Renmimbi.
Sales of Pharmaceutical Manufacturing saw an increase
56.1% in 2019, from
264.17 million Chinese Renmimbi to 412.50 million Chinese Renmimbi.
Not all segments of Jiangxi Synergy Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Others fell 81.2% to 554,698.21 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).